ATM and the molecular pathogenesis of ataxia telangiectasia

Annual Review of Pathology: Mechanisms of Disease

Volumn 7, Issue , 2012, Pages 303-321

  McKinnon, Peter J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Cerebellum; DNA damage; Genome instability; Neurodegeneration; Radiosensitivity

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNA; DNA DEPENDENT PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; RAD50 PROTEIN;

APRAXIA; ATAXIA TELANGIECTASIA; DEVELOPMENTAL DISORDER; DNA REPAIR; DOUBLE STRANDED DNA BREAK; HUMAN; MICROCEPHALY; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NIJMEGEN BREAKAGE SYNDROME; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; REVIEW; SECKEL SYNDROME; SEIZURE; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION;

ATAXIA TELANGIECTASIA; CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; NERVE DEGENERATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84856866360     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-011811-132509     Document Type: Review

References (150)

1. Gatti RA, Becker-Catania S, Chun HH, Sun X, Mitui M, et al. 2001. The pathogenesis of ataxiatelangiectasia. Learning from a Rosetta Stone. Clin. Rev. Allergy Immunol. 20:87-108 (Pubitemid 32223509)
2. McKinnon PJ. 2004. ATM and ataxia telangiectasia. EMBO Rep. 5:772-76
3. Sedgwick RP, Boder E. 1991. Ataxia-telangiectasia. In Handbook of Clinical Neurology, ed. P Vinken, G Bruyn, H Klawans, pp. 347-423. New York: Elsevier
4. Taylor AM, Byrd PJ. 2005. Molecular pathology of ataxia telangiectasia. J. Clin. Pathol. 58:1009-15 (Pubitemid 41416047)
5. Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. 2004. Immunodeficiency and infections in ataxia-telangiectasia. J. Pediatr. 144:505-11
6. Gumy-Pause F, Wacker P, Sappino AP. 2004.ATMgene and lymphoid malignancies. Leukemia 18:238-42
7. Sharma LM, Kashyap R, Gupta S, Bhargava M. 2008. B-cell acute lymphoblastic leukemia in a child with ataxia telangiectasia. Pediatr. Hematol. Oncol. 25:473-76 (Pubitemid 351874102)
8. Stankovic T, Stewart GS, Byrd P, Fegan C, Moss PA, Taylor AM. 2002. ATM mutations in sporadic lymphoid tumours. Leuk. Lymphoma 43:1563-71 (Pubitemid 34823478)
9. Angele S, Romestaing P, Moullan N, Vuillaume M, Chapot B, et al. 2003. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res. 63:8717-25 (Pubitemid 38064049)
10. Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, et al. 2006. ATM mutations that cause ataxiatelangiectasia are breast cancer susceptibility alleles. Nat. Genet. 38:873-75 (Pubitemid 44141653)
11. Thorstenson YR, Roxas A, Kroiss R, JenkinsMA, Yu KM, et al. 2003. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 63:3325-33 (Pubitemid 36735890)
12. McGrath-Morrow S, Lefton-GreifM, Rosquist K, Crawford T, Kelly A, et al. 2008. Pulmonary function in adolescents with ataxia telangiectasia. Pediatr. Pulmonol. 43:59-66
13. Schroeder SA, Swift M, Sandoval C, Langston C. 2005. Interstitial lung disease in patients with ataxiatelangiectasia. Pediatr. Pulmonol. 39:537-43 (Pubitemid 40696325)
14. Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9:759-69
15. Shiloh Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155-68 (Pubitemid 37328868)
16. Zoncu R, Efeyan A, Sabatini DM. 2011. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12:21-35
17. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, et al. 2010. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. USA 107:4153-58
18. Cam H, Easton JB, High A, Houghton PJ. 2010. mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. Mol. Cell 40:509-20
19. Falck J, Coates J, Jackson SP. 2005. Conserved modes of recruitment of ATM, ATR and DNA-PKCS to sites of DNA damage. Nature 434:605-11 (Pubitemid 40488547)
20. Frappart PO, McKinnon PJ. 2006. Ataxia-telangiectasia and related diseases. Neuromol. Med. 8:495-511
21. McKinnon PJ. 2009. DNA repair deficiency and neurological disease. Nat. Rev. Neurosci. 10:100-12
22. van der Burg M, Ijspeert H, Verkaik NS, Turul T, Wiegant WW, et al. 2009. A DNA-PKCS mutation in a radiosensitive TκB SCID patient inhibits Artemis activation and nonhomologous end-joining. J. Clin. Investig. 119:91-98
23. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. 2003. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat. Genet. 33:497-501 (Pubitemid 36390012)
24. Brown EJ, BaltimoreD. 2000.ATRdisruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14:397-402 (Pubitemid 30131885)
25. de Klein A, Muijtjens M, vanOs R, Verhoeven Y, Smit B, et al. 2000. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr. Biol. 10:479-82 (Pubitemid 30247338)
26. Frappart PO, McKinnon PJ. 2008. Mouse models of DNA double-strand break repair and neurological disease. DNA Repair 7:1051-60
27. Bakkenist CJ, Kastan MB. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506 (Pubitemid 36168436)
28. Kozlov SV, Graham ME, Jakob B, Tobias F, Kijas AW, et al. 2010. Autophosphorylation and ATM activation: Additional sites add to the complexity. J. Biol. Chem. 286:9107-19
29. Kozlov SV, Graham ME, Peng C, Chen P, Robinson PJ, Lavin MF. 2006. Involvement of novel autophosphorylation sites in ATM activation. EMBO J. 25:3504-14 (Pubitemid 44264861)
30. Sun Y, Jiang X, Chen S, Fernandes N, Price BD. 2005. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl. Acad. Sci. USA 102:13182-87 (Pubitemid 41324998)
31. Daniel JA, Pellegrini M, Lee JH, Paull TT, Feigenbaum L, Nussenzweig A. 2008. Multiple autophosphorylation sites are dispensable for murine ATM activation in vivo. J. Cell Biol. 183:777-83
32. So S, Davis AJ, Chen DJ. 2009. Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites. J. Cell Biol. 187:977-90
33. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. 2010. ATM activation by oxidative stress. Science 330:517-21
34. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER 3rd, Hurov KE, et al. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160-66 (Pubitemid 46877472)
35. Ciccia A, Elledge SJ. 2010. The DNA damage response: making it safe to play with knives. Mol. Cell 40:179-204
36. Derheimer FA, Kastan MB. 2010. Multiple roles of ATMin monitoring andmaintainingDNAintegrity. FEBS Lett. 584:3675-81
37. Stracker TH, Petrini JH. 2011. The MRE11 complex: starting from the ends. Nat. Rev. Mol. Cell Biol. 12:90-103
38. Caldecott KW. 2008. Single-strand break repair and genetic disease. Nat. Rev. Genet. 9:619-31
39. O'Driscoll M, Jeggo PA. 2006. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 7:45-54 (Pubitemid 41828947)
40. McKinnon PJ. 1987. Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum. Genet. 75:197-208 (Pubitemid 17036792)
41. Cleaver JE. 1969. Xeroderma pigmentosum: a human disease in which an initial stage of DNA repair is defective. Proc. Natl. Acad. Sci. USA 63:428-35
42. Cleaver JE. 2005. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat. Rev. Cancer 5:564-73 (Pubitemid 40942832)
43. Lee JH, Paull TT. 2007. Activation and regulation of ATM kinase activity in response to DNA doublestrand breaks. Oncogene 26:7741-48 (Pubitemid 350242454)
44. Williams GJ, Lees-Miller SP, Tainer JA. 2010. Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair 9:1299-306
45. Carson CT, Schwartz RA, Stracker TH, Lilley CE, LeeDV, Weitzman MD. 2003. TheMre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22:6610-20 (Pubitemid 38009607)
46. Difilippantonio S, Celeste A, Fernandez-Capetillo O, Chen HT, Reina SanMartin B, et al. 2005. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 7:675-85 (Pubitemid 40975748)
47. Kitagawa R, Bakkenist CJ, McKinnon PJ, Kastan MB. 2004. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18:1423-38 (Pubitemid 38780629)
48. Shull ER, Lee Y, Nakane H, Stracker TH, Zhao J, et al. 2009. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 23:171-80
49. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, Shiloh Y. 2003. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:5612-21 (Pubitemid 37279970)
50. Wu J, Chen Y, Lu LY, Wu Y, Paulsen MT, et al. 2011. Chfr and RNF8 synergistically regulate ATM activation. Nat. Struct. Mol. Biol. 18:761-68
51. Williams RS, Dodson GE, Limbo O, Yamada Y, Williams JS, et al. 2009. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 139:87-99
52. Hopfner KP, Craig L, Moncalian G, Zinkel RA, Usui T, et al. 2002. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 418:562-66 (Pubitemid 34851405)
53. Moreno-Herrero F, de JagerM, Dekker NH, Kanaar R, Wyman C, Dekker C. 2005. Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon bindingDNA. Nature 437:440-43 (Pubitemid 41613509)
54. Wiltzius JJ, Hohl M, Fleming JC, Petrini JH. 2005. The Rad50 hook domain is a critical determinant of Mre11 complex functions. Nat. Struct. Mol. Biol. 12:403-7 (Pubitemid 43085899)
55. Lukas C, Falck J, Bartkova J, Bartek J, Lukas J. 2003. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5:255-60 (Pubitemid 36322254)
56. Carney JP, Maser RS, Olivares H, Davis EM, Le Beau M, et al. 1998. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93:477-86 (Pubitemid 28232091)
57. Oba D, Hayashi M, Minamitani M, Hamano S, Uchisaka N, et al. 2010. Autopsy study of cerebellar degeneration in siblings with ataxia-telangiectasia- like disorder. Acta Neuropathol. 119:513-20
58. StewartGS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, et al. 1999. TheDNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99:577-87 (Pubitemid 30004634)
59. Taylor AM, Groom A, Byrd PJ. 2004. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair 3:1219-25 (Pubitemid 38997965)
60. Waltes R, Kalb R, GateiM, Kijas AW, Stumm M, et al. 2009. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am. J. Hum. Genet. 84:605-16
61. Williams RS, Moncalian G, Williams JS, Yamada Y, Limbo O, et al. 2008. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell 135:97-109
62. Matsumoto Y, Miyamoto T, Sakamoto H, Izumi H, Nakazawa Y, et al. 2011. Two unrelated patients with MRE11Amutations and Nijmegen breakage syndrome-like severemicrocephaly.DNARepair 10:314-21
63. Herzog KH, Chong MJ, Kapsetaki M, Morgan JI, McKinnon PJ. 1998. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 280:1089-91 (Pubitemid 28234952)
64. Lee Y, Barnes DE, Lindahl T, McKinnon PJ. 2000. Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. Genes Dev. 14:2576-80
65. Lee Y, Chong MJ, McKinnon PJ. 2001. Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J. Neurosci. 21:6687-93 (Pubitemid 32781113)
66. Orii KE, Lee Y, Kondo N, McKinnon PJ. 2006. Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development. Proc. Natl. Acad. Sci. USA 103:10017-22 (Pubitemid 43993615)
67. Kee Y, D'Andrea AD. 2010. Expanded roles of the Fanconi anemia pathway in preserving genomic stability. Genes Dev. 24:1680-94
68. Kuhne M, Riballo E, Rief N, Rothkamm K, Jeggo PA, Lobrich M. 2004. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res. 64:500-8 (Pubitemid 38120888)
69. Riballo E, Kuhne M, Rief N, Doherty A, Smith GC, et al. 2004. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to α-H2AX foci. Mol. Cell 16:715-24 (Pubitemid 39586530)
70. Goodarzi AA, Noon AT, Deckbar D, Ziv Y, Shiloh Y, et al. 2008. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31:167-77 (Pubitemid 352001394)
71. Ziv Y, Bielopolski D, Galanty Y, Lukas C, Taya Y, et al. 2006. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 8:870-76 (Pubitemid 44151591)
72. Noon AT, Shibata A, Rief N, Lobrich M, Stewart GS, et al. 2010. 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat. Cell Biol. 12:177-84
73. Kriaucionis S, Heintz N. 2009. The nuclear DNA base 5- hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324:929-30
74. Das BB, Antony S, Gupta S, Dexheimer TS, Redon CE, et al. 2009. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J. 28:3667-80
75. Dong Z, Tomkinson AE. 2006. ATM mediates oxidative stress-induced dephosphorylation of DNA ligase III. Nucleic Acids Res. 34:5721-279
76. Bekker-Jensen S, Fugger K, Danielsen JR, Gromova I, Sehested M, et al. 2007. Human Xip1 (C2orf13) is a novel regulator of cellular responses to DNA strand breaks. J. Biol. Chem. 282:19638-43 (Pubitemid 47100052)
77. Iles N, Rulten S, El-Khamisy SF, Caldecott KW. 2007. APLF (C2orf13) is a novel human protein involved in the cellular response to chromosomal DNA strand breaks. Mol. Cell Biol. 27:3793-803 (Pubitemid 46726186)
78. Macrae CJ, McCulloch RD, Ylanko J, Durocher D, Koch CA. 2008. APLF (C2orf13) facilitates nonhomologous end-joining and undergoes ATM-dependent hyperphosphorylation following ionizing radiation. DNA Repair 7:292-302
79. Beucher A, Birraux J, Tchouandong L, Barton O, Shibata A, et al. 2009. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J. 28:3413-27
80. Helmink BA, Tubbs AT, Dorsett Y, Bednarski JJ, Walker LM, et al. 2011.H2AXprevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature 469:245-49
81. Morrison C, Sonoda E, Takao N, Shinohara A, Yamamoto K, Takeda S. 2000. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 19:463-71 (Pubitemid 30072616)
82. Sakamoto S, Iijima K, Mochizuki D, Nakamura K, Teshigawara K, et al. 2007. Homologous recombination repair is regulated by domains at the N- and C-terminus of NBS1 and is dissociated with ATM functions. Oncogene 26:6002-9 (Pubitemid 47373808)
83. You Z, Shi LZ, Zhu Q, Wu P, Zhang YW, et al. 2009. CtIP links DNA double-strand break sensing to resection. Mol. Cell 36:954-69
84. Barlow C, Liyanage M, Moens PB, Deng CX, Ried T, Wynshaw-Boris A. 1997. Partial rescue of the prophase I defects of Atm-deficient mice by p53 and p21 null alleles. Nat. Genet. 17:462-66 (Pubitemid 27518398)
85. Zha S, Guo C, Boboila C, Oksenych V, Cheng HL, et al. 2011. ATM damage response and XLF repair factor are functionally redundant in joining DNA breaks. Nature 469:250-54
86. Zha S, Jiang W, Fujiwara Y, Patel H, Goff PH, et al. 2011. Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions. Proc. Natl. Acad. Sci. USA 108:2028-33
87. Callen E, Jankovic M, Difilippantonio S, Daniel JA, Chen HT, et al. 2007.ATMprevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 130:63-75 (Pubitemid 47031324)
88. Gurley KE, Kemp CJ. 2001. Synthetic lethality between mutation in Atm and DNA-PKCS duringmurine embryogenesis. Curr. Biol. 11:191-94 (Pubitemid 32152105)
89. Zha S, Sekiguchi J, Brush JW, Bassing CH, Alt FW. 2008. Complementary functions ofATMand H2AX in development and suppression of genomic instability. Proc. Natl. Acad. Sci. USA 105:9302-6
90. Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX. 2002. Ocular manifestations of ataxia-telangiectasia. Am. J. Ophthalmol. 134:891-96 (Pubitemid 35425459)
91. Farina L, Uggetti C, Ottolini A, Martelli A, Bergamaschi R, et al. 1994. Ataxia-telangiectasia: MR and CT findings. J. Comput. Assist. Tomogr. 18:724-27 (Pubitemid 24286362)
92. Sardanelli F, Parodi R, Ottonello C, Renzetti P, Saitta S, et al. 1995. Cranial MRI in ataxia-telangiectasia. Neuroradiology 37:77-82
93. Tavani F, Zimmerman RA, Berry GT, Sullivan K, Gatti R, Bingham P. 2003. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology 45:315-19 (Pubitemid 36656622)
94. Paula-Barbosa MM, Ruela C, Tavares MA, Pontes C, Saraiva A, Cruz C. 1983. Cerebellar cortex ultrastructure in ataxia-telangiectasia. Ann. Neurol. 13:297-302 (Pubitemid 13158538)
95. Baptista CA, Hatten ME, Blazeski R, Mason CA. 1994. Cell-cell interactions influence survival and differentiation of purified Purkinje cells in vitro. Neuron 12:243-60 (Pubitemid 24071291)
96. Smeyne RJ, Chu T, Lewin A, Bian F, Sanlioglu S, et al. 1995. Local control of granule cell generation by cerebellar Purkinje cells. Mol. Cell Neurosci. 6:230-51
97. Gatti RA, Vinters HV. 1985. Cerebellar pathology in ataxia- telangiectasia: the significance of basket cells. In Kroc Foundation Series, ed. RA Gatti, M Swift, pp. 225-32. New York: Liss
98. Goldowitz D, Hamre K. 1998. The cells and molecules that make a cerebellum. Trends Neurosci. 21:375-82 (Pubitemid 28384554)
99. Malandrini A, Guazzi GC, Alessandrini C, Federico A. 1990. Peripheral nerve involvement in ataxia telangiectasia: histological and ultrastructural studies of peroneal nerve biopsy in two cases. Clin. Neuropathol. 9:109-14 (Pubitemid 20285581)
100. Soares HD, Morgan JI, McKinnon PJ. 1998. Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia. Neuroscience 86:1045-54 (Pubitemid 28318531)
101. Gilad S, Chessa L, Khosravi R, Russell P, Galanty Y, et al. 1998. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet. 62:551-61 (Pubitemid 28164612)
102. Toyoshima M, Hara T, Zhang H, Yamamoto T, Akaboshi S, et al. 1998. Ataxia-telangiectasia without immunodeficiency: novel point mutations within and adjacent to the phosphatidylinositol 3-kinase-like domain. Am. J. Med. Genet. 75:141-44 (Pubitemid 28034489)
103. Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, et al. 2009. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 73:430-37
104. Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, et al. 2001. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat. Genet. 29:184-88 (Pubitemid 32952656)
105. el-Khamisy SF, Caldecott KW. 2007. DNA single-strand break repair and spinocerebellar ataxia with axonal neuropathy-1. Neuroscience 145: 1260-66 (Pubitemid 46602725)
106. Moreira MC, Barbot C, Tachi N, Kozuka N, Uchida E, et al. 2001. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 29:189-93 (Pubitemid 32952657)
107. Onodera O. 2006. Spinocerebellar ataxia with ocular motor apraxia and DNA repair. Neuropathology 26:361-67 (Pubitemid 44086841)
108. Rass U, Ahel I, West SC. 2007. DefectiveDNA repair and neurodegenerative disease. Cell 130:991-1004
109. Takashima H, Boerkoel CF, John J, Saifi GM, Salih MA, et al. 2002. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 32:267-72
110. Aicardi J, Barbosa C, Andermann E, Andermann F, Morcos R, et al. 1988. Ataxia-ocular motor apraxia: a syndrome mimicking ataxia-telangiectasia. Ann. Neurol. 24:497-502
111. Le Ber I, Bouslam N, Rivaud-Pechoux S, Guimaraes J, Benomar A, et al. 2004. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain 127:759-67 (Pubitemid 38478520)
112. El-Khamisy SF, Saifi GM, Weinfeld M, Johansson F, Helleday T, et al. 2005. Defective DNA singlestrand break repair in spinocerebellar ataxia with axonal neuropathy 1. Nature 434:108-13 (Pubitemid 40349394)
113. AlmeidaKH, SobolRW.2007.Aunified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair 6:695-711 (Pubitemid 46670095)
114. Wilson DM 3rd, Bohr VA. 2007. The mechanics of base excision repair, and its relationship to aging and disease. DNA Repair 6:544-59 (Pubitemid 46357056)
115. Connelly JC, Leach DR. 2004. Repair of DNA covalently linked to protein. Mol. Cell 13:307-16 (Pubitemid 38229804)
116. Interthal H, Chen HJ, Kehl-Fie TE, Zotzmann J, Leppard JB, Champoux JJ. 2005. SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity. EMBO J. 24:2224-33 (Pubitemid 40961806)
117. Miao ZH, Agama K, Sordet O, Povirk L, Kohn KW, Pommier Y. 2006. Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes. DNA Repair 5:1489-94 (Pubitemid 44739452)
118. Wang JC. 2002. Cellular roles of DNA topoisomerases: a molecular perspective. Nat. Rev. Mol. Cell Biol. 3:430-40 (Pubitemid 34685700)
119. Zhou T, Lee JW, Tatavarthi H, Lupski JR, Valerie K, Povirk LF. 2005. Deficiency in 3′- phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res. 33:289-97 (Pubitemid 40276950)
120. Ahel I, Rass U, El-Khamisy SF, Katyal S, Clements PM, et al. 2006. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 443:713-16 (Pubitemid 44564716)
121. Seidle HF, Bieganowski P, Brenner C. 2005. Disease-associated mutations inactivate AMP-lysine hydrolase activity of aprataxin. J. Biol. Chem. 280:20927-31 (Pubitemid 40805648)
122. Shen J, Gilmore EC, Marshall CA, Haddadin M, Reynolds JJ, et al. 2010. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat. Genet. 42:245-49
123. Barlow C, Dennery PA, Shigenaga MK, Smith MA, Morrow JD, et al. 1999. Loss of the ataxiatelangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96:9915-19 (Pubitemid 29398832)
124. Chen P, Peng C, Luff J, Spring K, Watters D, et al. 2003. Oxidative stress is responsible for deficient survival and dendritogenesis in Purkinje neurons from ataxia-telangiectasia mutated mutant mice. J. Neurosci. 23:11453-60 (Pubitemid 37549702)
125. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, et al. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61:1849-54 (Pubitemid 32691998)
126. Quick KL, Dugan LL. 2001. Superoxide stress identifies neurons at risk in a model of ataxiatelangiectasia. Ann. Neurol. 49:627-35 (Pubitemid 32429789)
127. Reichenbach J, Schubert R, Schindler D, Muller K, Bohles H, Zielen S. 2002. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4:465-69 (Pubitemid 34753385)
128. Stern N, Hochman A, Zemach N, Weizman N, Hammel I, et al. 2002. Accumulation of DNA damage and reduced levels of nicotine adenine dinucleotide in the brains of Atm-deficient mice. J. Biol. Chem. 277:602-8 (Pubitemid 34952097)
129. Cosentino C, Grieco D, Costanzo V. 2011. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 30:546-55
130. Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, et al. 2004. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431:997-1002 (Pubitemid 39434422)
131. Leonard JC, Mullinger AM, Schmidt J, Cordell HJ, Johnson RT. 2004. Genome instability in ataxia telangiectasia (A-T) families: Camptothecin-induced damage to replicating DNA discriminates between obligate A-T heterozygotes, A-T homozygotes and controls. Biosci. Rep. 24:617-29 (Pubitemid 41297982)
132. Li J, HanYR, PlummerMR, HerrupK. 2009. CytoplasmicATMin neuronsmodulates synaptic function. Curr. Biol. 19:2091-96
133. Lim DS, Kirsch DG, Canman CE, Ahn JH, Ziv Y, et al. 1998. ATM binds to α-adaptin in cytoplasmic vesicles. Proc. Natl. Acad. Sci. USA 95:10146-51 (Pubitemid 28415309)
134. Watters D, Kedar P, Spring K, Bjorkman J, Chen P, et al. 1999. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274:34277-82 (Pubitemid 129511769)
135. Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. 2003. Sequential modification of NEMO/IKKby SUMO-1 and ubiquitin mediates NF-κB activation by genotoxic stress. Cell 115:565-76 (Pubitemid 37506045)
136. Bredemeyer AL, Helmink BA, Innes CL, Calderon B, McGinnis LM, et al. 2008. DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature 456:819-23
137. Rashi-Elkeles S, Elkon R, Weizman N, Linhart C, Amariglio N, et al. 2006. Parallel induction of ATMdependent pro- and antiapoptotic signals in response to ionizing radiation in murine lymphoid tissue. Oncogene 25:1584-92 (Pubitemid 43361943)
138. Wu ZH, Shi Y, Tibbetts RS, Miyamoto S. 2006. Molecular linkage between the kinase ATMandNF-κB signaling in response to genotoxic stimuli. Science 311:1141-46
139. Hinz M, Stilmann M, Arslan SC, Khanna KK, Dittmar G, Scheidereit C. 2010. A cytoplasmic ATMTRAF6- cIAP1 module links nuclear DNA damage signaling to ubiquitin-mediated NF-κB activation. Mol. Cell 40:63-74
140. Wu ZH, Wong ET, Shi Y, Niu J, Chen Z, et al. 2010. ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress. Mol. Cell 40:75-86
141. Yang DQ, Kastan MB. 2000. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2:893-98
142. KimWS, Elliott DA, KockxM, Kritharides L, Rye KA, et al. 2008. Analysis of apolipoprotein E nuclear localization using green fluorescent protein and biotinylation approaches. Biochem. J. 409:701-9 (Pubitemid 351214196)
143. Wong RH, Chang I, Hudak CS, Hyun S, Kwan HY, Sul HS. 2009. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 136:1056-72
144. Ambrose M, Goldstine JV, Gatti RA. 2007. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 16:2154-64 (Pubitemid 47354898)
145. Eaton JS, Lin ZP, Sartorelli AC, Bonawitz ND, Shadel GS. 2007. Ataxia-telangiectasia mutated kinase regulates ribonucleotide reductase and mitochondrial homeostasis. J. Clin. Investig. 117:2723-34 (Pubitemid 47494372)
146. DiMauro S, Schon EA. 2008. Mitochondrial disorders in the nervous system. Annu. Rev. Neurosci. 31:91-123
147. Yang Y, Herrup K. 2005. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J. Neurosci. 25:2522-29 (Pubitemid 40365163)
148. Inomata K, Aoto T, BinhNT, OkamotoN, Tanimura S, et al. 2009. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 137:1088-99
149. Nijnik A, Woodbine L, Marchetti C, Dawson S, Lambe T, et al. 2007. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 447:686-90 (Pubitemid 46889732)
150. Rossi DJ, Bryder D, Seita J, Nussenzweig A, Hoeijmakers J, Weissman IL. 2007. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 447:725-29 (Pubitemid 46889729)